Abstract
Purpose
Differences in incidence and prevalence of ADHD medication use between ethnic groups have been reported. Goal of this study was to determine whether there are also differences in usage patterns of ADHD medication among native Dutch children and adolescents and those with a Moroccan, Turkish and Surinam cultural background in the Netherlands between 1999 and 2010.
Methods
In a cohort of ADHD patients <19 years (N = 817) incident use and discontinuation of ADHD medication were measured for ethnicity and adjusted for age, gender and socio-economic status.
Results
A significant higher proportion of ADHD-diagnosed patients from Moroccan (32 %) and Turkish (42 %) cultural background never used ADHD medication compared to Dutch natives (21 %). One-fifth of native Dutch and Turkish patients already used ADHD medication before the ADHD diagnosis date. Discontinuation of ADHD medication within 5 years was significantly higher in Moroccan [HR 2.4 (95 % CI 1.8–3.1)] and Turkish [HR 1.7 (95 % CI 1.1–2.6)] patients. A sensitivity analysis with a zip code-matched comparison between Dutch natives and non-natives showed similar results, suggesting this effect is probably not explained by socio-economic status (SES).
Conclusion
Differences are found in prescribing and use of ADHD medication between patients with a different cultural background. Native Dutch and Turkish patients start more frequently with ADHD medication before the ADHD diagnose date, which can be an indication of differences in either referral patterns and/or access to care. A higher percentage of patients with a Moroccan and Turkish cultural background never start using ADHD medication at all and discontinuation rate is higher compared to Dutch natives and Surinamese.
References
Aacap ADHD Guideline (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46(7):894–921
Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K et al (2007) British Association for Psychopharmacology. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 21(1):10–41
Atkinson M, Hollis C (2010) NICE guideline: attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed 95(1):24–27
Murphy K, Barkley R (1996) Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Atten Disorder 3:147–161
McDonnell MA, Glod C (2003) Prevalence of psychopathology in preschool-age children. Child Adolesc Psychiatr Nurs 16(4):141–152
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O et al (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716–723
Ten Have M, Graaf de R, Dorsselaer S, Verdurmen J, Land van’t H, Vollenbergh W et al (2006) Prevalentie van impulsstoornissen. Resultaten van the European Study of Epidemiology of Mental Disorders (ESEMeD). Trimbos Instituut, Utrecht
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and meta-regression analysis. Am J Psychiatry 164(6):942–948
de Ridder T, Bruffaerts R, Danckaerts M, Bonnewyn A, Demyttenaere K (2008) ADHD in de Belgische bevolking; een epidemiologische exploratieve studie. Tijdschr Psychiatr 50(8):499–508
Michielsen M, Semeijn E, Comijs HC, van de Ven P, Beekman AT, Deeg DJ et al (2012) Prevalence of attention-deficit hyperactivity disorder in older adults in the Netherlands. Br J Psychiatry 201(4):298–305
Wichstrøm L, Berg-Nielsen TS, Angold A, Egger HL, Solheim E, Sveen TH (2012) Prevalence of psychiatric disorders in preschoolers. J Child Psychol Psychiatry 53(6):695–705
Robison L, Sclar D, Traer T, Galins R (1999) National trends in prevalence of attention-deficit/hyperactivity disorder and the prescription of methylphenidate among school-age children: 1990–1995. Clin Pediatrics 38:209–217
Miller A, Lalonde C, McGrail K, Armstrong R (2001) Prescription of methylphenidate to children and youth, 1990–1996. Can Med Assoc J 165:1489–1494
Schirm E, Tobi H, Zito J, de Jong-van den Berg LT (2001) Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:E25–E29
Zito J, Safer D, dosReis S et al (2000) Trends in prescribing of psychotropic medications to preschoolers. JAMA 83:1025–1030
Reid R, Hakendorf P, Prosser B (2002) Use of stimulant medication for ADHD in South Australia. J Am Acad Child Adolesc Psychiatry 41:906–913
Hugtenburg J, Heerdink E, Egberts A (2004) Increased psychotropic drug consumption by children in the Netherlands during 1995–2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol 60:377–379
Faber A, de Jong-van den Berg LT, van den Berg PB, Tobi H (2005) Psychotropic comedication among stimulant-treated children in the Netherlands. J Child Adolesc Psychofarm 15:38–43
Robison L, Sclar D, Skaer T (2005) Trends in ADHD and stimulant use among adults: 1995–2002. Psychiatr Serv 56:1497
Vinker S, Vinker R, Elhayany A (2006) Prevalance of methylphenidate use among Israeli children: 1998–2004. Clin Drug Investig 26:161–167
Castle L, Aubert R, Verbrugge R, Khalid M, Epstein R (2007) Trends in medication treatment for ADHD. J Att Disord 10:335–342
Zito J, Safer D, Satish Valluri M, Gardner J, Korelitz J, Mattison D (2007) Psychotherapeutic medication prevalence in medicaid-insured preschoolers. J Child Adolesc Psychofarm 17:195–203
Winterstein A, Gerhard T, Shuster J, Zito J, Johnson M (2008) Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in medicaid database. Ann Pharmacother 42:24–31
van den Ban E, Souverein P, Swaab H, van Engeland H, Heerdink R, Egberts T (2010) Incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001–2006. J Child Adolesc Psychopharmacol 20:55–61
Comer J, Olfson M, Mojtabai R (2010) National trends in child and adolescent psychotropic polypharmacy in office based practice, 1996–2007. J Am Acad Child Adolesc Psychiatry 49(10):1001–1010
Hodgkins P, Sasane R, Meijer WM (2011) Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Ther 3:188–203
Fullerton CA, Epstein AM, Frank RG, Normand SL, Fu CX, McGuire TG (2012) Medication use and spending trends among children with ADHD in Florida’s Medicaid program, 1996–2005. Psychiatr Serv 63(2):115–121
Lindemann C, Langner I, Kraut A, Banaschewski T, Schad-Hansjosten T, Petermann U et al (2012) Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. J Child Adolesc Psychopharmacol 22(4):307–314
Zuvekas S, Vitiello B (2012) Stimulant medication use in children: a 12-year perspective. Am J Psychiatry 169(2):160–166
Raghavan R, Brown DS, Thompson H, Ettner SL, Clements LM, Key W (2012) Medicaid expenditures on psychotropic medications for children in the child welfare system. J Child Adolesc Psychopharmacol 22(3):182–189
Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA (1997) Methylphenidate patterns among medicaid youths. Psychopharmacol Bull 33(1):143–147
Blanco C, Patel SR, Liu L, Jiang H, Lewis-Fernández R, Schmidt AB et al (2007) National trends in ethnic disparities in mental health care. Med Care 45(11):1012–1019
Bauermeister JJ, Canino G, Bravo M, RamÃrez R, Jensen PS, Chavez L et al (2003) Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children. J Am Acad Child Adolesc Psychiatry 42(7):851–855
Bussing R, Zima BT, Mason D, Hou W, Garvan CW, Forness S (2005) Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15(1):78–87
dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL (2005) Multiple psychotropic medication use for youths: a two-state comparison. J Child Adolesc Psychopharmacol 15(1):68–77
Radigan M, Lannon P, Roohan P, Gesten F (2005) Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population. J Child Adolesc Psychopharmacol 15(1):44–56
Raghavan R, Zima BT, Andersen RM, Leibowitz AA, Schuster MA, Landsverk J (2005) Psychotropic medication use in a national probability sample of children in the child welfare system. J Child Adolesc Psychopharmacol 15(1):97–106
Stevens J, Harman JS, Kelleher KJ (2005) Race/ethnicity and insurance status as factors associated with ADHD treatment patterns. J Child Adolesc Psychopharmacol 15(1):88–96
Zito JM, Safer DJ, Zuckerman IH, Gardner JF, Soeken K (2005) Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatr Serv 56(2):157–163
Bruckner TA, Hodgson A, Mahoney CB, Fulton BD, Levine P, Scheffler RM (2012) Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications. Pharmacoepidemiol Drug Saf 21(4):442–449
Brown RT, Sexson SB (1988) A controlled trial of methylphenidate in black adolescents. Attentional, behavioral, and physiological effects. Clin Pediatr (Phila) 27(2):74–81
Arnold LE, Elliot M, Sachs L, Bird H, Kraemer HC, Wells KC et al (2003) Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol 71(4):713–727
Bauermeister JJ, Bird HR, Shrout PE, Chavez L, RamÃrez R, Canino G (2011) Short-term persistence of DSM-IV ADHD diagnoses: influence of context, age, and gender. Am Acad Child Adolesc Psychiatry 50(6):554–562
Statistics Netherlands (CBS) (2005) StatLine database. http://www.cbs.nl/NR/rdonlyres/92AA630F-7BD8-4DFB-B27D-A7229D329204/0/2005eindrapportmgzpub.pdf. Accessed 16 Oct 2014
Statistics Netherlands (CBS) (2005) StatLine database. http://www.cbs.nl/nl-NL/. Accessed 3 Jan 2014
Zwirs BW, Burger H, Schulpen TW, Wiznitzer M, Fedder H, Buitelaar JK (2007) Prevalence of psychiatric disorders among children of different ethnic origin. J Abnorm Child Psychol 35(4):556–566
Boon E, De Haan AM, De Boer S (2010) Verschillen in etnische achtergrond van forensische en reguliere jeugd-ggz-cliënten. Kind en Adolescent 13:16–28
Zwirs BW, Burger H, Buitelaar JK, Schulpen TW (2006) Ethnic differences in parental detection of externalizing disorders. Eur Child Adolesc Psychiatry 15(7):418–426
Nuijen J, Romijn G, van Mierlo F, van der Zanden A, Onrust S (2010) Psychische problematiek bij kinderen en jongeren: 135 Over ontwikkelingen in het vóórkomen, de toegang tot en het gebruik van de jeugd-GGZ Trimbos-instituut, Utrecht, Netherlands, Institute of Mental health and addiction, pp 135–175
Scheppers E, van Dongen E, Dekker J, Geertzen J, Dekker J (2006) Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract 23(3):325–348
Alegria M, Lin J, Green J, Sampson N, Gruber M, Kessler M (2012) Role of referrals in mental health service disparities for racial and ethnic minority youth. J Am Ac Child Adolesc Psychiatry 51(7):703–711.e2
Verhulp EE, Stevens GW, van de Schoot R, Vollebergh WA (2013) Understanding ethnic differences in mental health service use for adolescents’ internalizing problems: the role of emotional problem identification. Eur Child Adolesc Psychiatry 22(7):413–421
Wittkampf L, Smeets H, Knol M, Geerlings M, Bram A, de Wit N (2010) Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands. Soc Psychiat Epidemiol 45:819–826
Lipkin PH, Cozen MA, Thompson RE, Mostofsky SH (2005) Stimulant dosage and age, race, and insurance type in a sample of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15(2):240–248
Knol F (2012) Development status of Dutch neighborhoods 1998–2010. Sociaal Cultureel Planbureau (in Dutch)
Tolan PH, Henry D (1996) Patterns of psychopathology among urban poor children: comorbidity and aggression effects. J Consult Clin Psychol 64(5):1094–1099
Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H et al (2013) Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. J Child Psychol Psychiatry 54(5):527–535
Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J et al (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15(8):476–495
Brown R, Pacini J (1989) Perceived family functioning, marital status, and depression in parents of boys with attention deficit disorder. J Learn Disab 22(9):581–587
Barkley R, Guevremont D, Anastopoulos A, DuPaul G, Shelton T (1993) Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 92(2):212–218
Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O’Brien PC (2001) Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. J Am Med Assoc 285(1):60–66
Swensen AR, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, Claxton A (2003) Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Ac Child Adolesc Psychiatry 42(12):1415–1423
Swensen A, Birnbaum H, Hamadi R, Greenberg P, Cremieux P, Secnik K (2004) Incidence and costs of accidents among attention/deficit disorder patients. J Adolesc Health 35:346e1–346e9
Hakkaart-van Roijen L, Zwirs B, Bouwmans C, Tan S, Schulpen T, Vlasveld L et al (2007) Social costs and quality of life of children suffering from attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 16:316–326
Coghill D, Soutello C, d’ Aubuisson C, Preuss U, Lindback T, Silverberg M et al (2008) Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. J Child Adolesc Psychiatry Ment Health 2(1):31
Sobanski E, Brüggemann D, Alm B, Kern S, Philipsen A, Schmalzried H et al (2008) Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry 23:142–149
Bussing R, Mason D, Bell L, Porter P, Garvan C (2010) adolescent outcome of childhood attention-deficit/hyperactivity disorder in a diverse community sample. J Am Acad Cild Adolesc Psychiatry 49(6):595–605
Meyers J, Classi P, Wietecha L, Candrill S (2010) Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States. Child Adolesc Psychiatry Ment Health 14(4):31
Charach A, Yeung E, Climans T, Lillie E (2011) Childhood attention deficit/hyperactivity disorder and the future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 50:9–21
Lee S, Humphreys K, Flory K, Liu R, Glass K (2011) Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 31:328–341
Ginsberg Y, Långström N, Larsson H, Lichtenstein P (2013) ADHD and criminality: could treatment benefit prisoners with ADHD who are at higher risk of reoffending? Expert Rev Neurother 13(4):345–348
Lichtenstein P, Halldner L, Zetterqvist J, Sjölander A, Serlachius E, Fazel S et al (2012) Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 367(21):2006–2014
Statistics Netherlands (CBS) (2010) StatLine database. http://www.cbs.nl/nl-NL/menu/themas/gezondheid-welzijn/publicaties/artikelen/archief/2010/2010-3087-wm.htm. Accessed 16 Oct 2014
Statistics Netherlands (CBS) (2007) StatLine database. Bevolkingstrends, 4e kwartaal. http://www.cbs.nl. Accessed 16 Oct 2014
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van den Ban, E.F., Souverein, P.C., van Engeland, H. et al. Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands. Soc Psychiatry Psychiatr Epidemiol 50, 1153–1162 (2015). https://doi.org/10.1007/s00127-015-1068-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00127-015-1068-4